Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluation of Chylothorax Using Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography After Lung Cancer Surgery.

  • Authors : Choe J; Department of Radiology and Research Institute of Radiology and University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.; Koo HJ

Subjects: Chylothorax*/Chylothorax*/Chylothorax*/diagnostic imaging ; Chylothorax*/Chylothorax*/Chylothorax*/etiology ; Chylothorax*/Chylothorax*/Chylothorax*/therapy

  • Source: Lymphatic research and biology [Lymphat Res Biol] 2023 Aug; Vol. 21 (4), pp. 343-350. Date of Electronic Publication: 2023 Mar 07.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101163587 Publication Model: Print-Electronic

Record details

×
Academic Journal

LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.

  • Authors : Cui J; Department of Thoracic Surgery and Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Wang Y

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/genetics ; Adenocarcinoma of Lung* ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 Sep; Vol. 39 (7-9), pp. 491-511.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print Cited

Record details

×
Academic Journal

Evaluation of Early Results Video-Assisted Thoracoscopic Surgery with Multi-Joint Wristed Instruments in Lung Cancer Surgery.

  • Authors : Sezen CB; Department of Thoracic Surgery, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.; Dogru MV

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/surgery ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/surgery

  • Source: Journal of laparoendoscopic & advanced surgical techniques. Part A [J Laparoendosc Adv Surg Tech A] 2023 Jul; Vol. 33 (7), pp. 626-631. Date of Electronic Publication: 2023 Mar 29.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9706293 Publication Model: Print-Electronic

Record details

×
Academic Journal

Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating ABCC1 Through miR-186-5p.

  • Authors : Wang X; Department of Pharmacy Intravenous Admixture Service, Weifang People's Hospital, Weifang, China.; Wang H

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Jun; Vol. 38 (5), pp. 293-304. Date of Electronic Publication: 2021 Aug 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Efficacy and Safety of Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Patients with Lung Cancer Who Were Complicated with Hemoptysis.

  • Authors : Fu Z; Department of Radiology, Yichang Central People's Hospital, First College of Clinical Medical Science, China Three Gorges University, Yichang, China.; Guo J

Subjects: Chemoembolization, Therapeutic*/Chemoembolization, Therapeutic*/Chemoembolization, Therapeutic*/adverse effects ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/complications ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/therapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Jun; Vol. 38 (5), pp. 347-352. Date of Electronic Publication: 2020 Oct 14.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Long Noncoding RNA RP11-89K21.1 Interacts with miR-146a/b-5p to Promote Proliferation and Gefitinib Resistance Through Regulating RHPN2 and RhoA/ROCK Pathway in Lung Adenocarcinoma.

  • Authors : Chen H; Department of Tuberculosis, Wuxi No. 5 People's Hospital, Wuxi, China.; Shen D

Subjects: RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/metabolism ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Jun; Vol. 38 (5), pp. 282-292. Date of Electronic Publication: 2021 Apr 20.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Core Fucosylation Is Required for the Secretion of and the Enzymatic Activity of SOD3 in Nonsmall-Cell Lung Cancer Cells.

  • Authors : Ohkawa Y; Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka, Japan.; Kitano M

Subjects: Carcinoma, Non-Small-Cell Lung* ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 Jun; Vol. 38 (16-18), pp. 1201-1211. Date of Electronic Publication: 2023 Mar 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review.

  • Authors : Sidrak MMA; Nuclear Medicine, Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.; De Feo MS

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/diagnostic imaging ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 May; Vol. 38 (4), pp. 232-245. Date of Electronic Publication: 2023 Jan 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Can Baseline [ 18 F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.

  • Authors : Bianchi A; Nuclear Medicine Unit, SC Medicina Nucleare, ASO S.Croce e Carle Cuneo, Cuneo, Italy.; De Rimini ML

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/diagnostic imaging ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 May; Vol. 38 (4), pp. 256-267. Date of Electronic Publication: 2023 Apr 25.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Circular RNA cMras Suppresses the Progression of Lung Adenocarcinoma Through ABHD5 / ATGL Axis Using NF-κB Signaling Pathway.

  • Authors : Zhou Q; Department of Comprehensive Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China.; Sun Y

Subjects: Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/genetics ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/pathology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Jun; Vol. 38 (5), pp. 336-346. Date of Electronic Publication: 2020 Aug 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×